Novel Oropharyngeal Airway
common.study.values.description
“Investigation of a Novel Oropharyngeal Airway: The ManMaxAirway”
Guedel pattern or oropharyngeal airways (OPA) maintain an open oral airway in unconscious or semi-conscious patients by preventing the tongue from covering the epiglottis, but OPA placement carries a risk of inducing gag reflex and vomiting. Although various sizes are available, the design of the OPA has undergone little change since its introduction in the 1920s. The purpose of this study is to determine the utility of a novel airway device, the ManMaxAirway (MMA), as an alternative to the OPA.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Device - ManMaxAirway oropharyngeal airway adjunct
Healthy volunteers will self-place the ManMaxAirway.
Device - Guedel Oropharyngeal airway adjunct
Healthy volunteers will self-place the standard Guedel OPA.
Device - No airway adjunct
Healthy volunteers will have no airway adjunct in place.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Investigation of a Novel Oropharyngeal Airway: The ManMaxAirway
common.study.values.clinical-trial-id
NCT03969147
participant.views.study.view.id
aOYDRd
